Cargando…
Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?
Patients with benign prostatic hyperplasia (BPH) can exhibit various lower urinary tract symptoms (LUTS) owing to bladder outlet obstruction (BOO), prostatic inflammation, and bladder response to BOO. The pathogenesis of BPH involves an imbalance of internal hormones and chronic prostatic inflammati...
Autores principales: | Chiang, Bing-Juin, Kuo, Hann-Chorng, Liao, Chun-Hou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784075/ https://www.ncbi.nlm.nih.gov/pubmed/31546892 http://dx.doi.org/10.3390/toxins11090547 |
Ejemplares similares
-
Current consensus and controversy on the treatment of male lower urinary tract symptoms/benign prostatic hyperplasia
por: Liao, Chun-Hou, et al.
Publicado: (2017) -
Current consensus and controversy on the diagnosis of male lower urinary tract symptoms/benign prostatic hyperplasia
por: Lee, Cheng-Ling, et al.
Publicado: (2017) -
Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction
por: Kuo, Hann-Chorng
Publicado: (2020) -
Precision medicine in the diagnosis and treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia
por: Chen, Jing-Liang, et al.
Publicado: (2019) -
Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)